Review
doi: 10.1136/bmj.318.7181.456.
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold
Affiliations
- PMID: 9974468
- PMCID: PMC1114914
- DOI: 10.1136/bmj.318.7181.456
Item in Clipboard
Review
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold
BMJ.
.
No abstract available
Figures
As newer, better tolerated treatments are offered, the number of patients will expand
Comment in
-
Lack of funding will inhibit evidence based commissioning of cancer treatments.BMJ. 2000 Jan 1;320(7226):54. BMJ. 2000. PMID: 10617538 Free PMC article. No abstract available.
Similar articles
-
Managing oncology drug costs in a constrained environment.Clin Adv Hematol Oncol. 2019 Feb;17(2):90-93. Clin Adv Hematol Oncol. 2019. PMID: 30845110 No abstract available.
-
Understanding the value of cancer drugs-the devil is in the detail.Cancer. 2016 Aug 1;122(15):2292-5. doi: 10.1002/cncr.30044. Epub 2016 May 10. Cancer. 2016. PMID: 27163796 No abstract available.
-
A question of health. The lottery of cancer care.Health Serv J. 1997 Dec 18;107(5584):suppl 1-4 following 24. Health Serv J. 1997. PMID: 10184833 No abstract available.
-
Drug repurposing in oncology--patient and health systems opportunities.Nat Rev Clin Oncol. 2015 Dec;12(12):732-42. doi: 10.1038/nrclinonc.2015.169. Epub 2015 Oct 20. Nat Rev Clin Oncol. 2015. PMID: 26483297 Review.
-
Community oncology in an era of payment reform.Am Soc Clin Oncol Educ Book. 2014:e447-52. doi: 10.14694/EdBook_AM.2014.34.e447. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857138 Review.
Cited by
-
Lack of funding will inhibit evidence based commissioning of cancer treatments.BMJ. 2000 Jan 1;320(7226):54. BMJ. 2000. PMID: 10617538 Free PMC article. No abstract available.
-
Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario.Curr Oncol. 2013 Feb;20(1):e21-33. doi: 10.3747/co.20.1166. Curr Oncol. 2013. PMID: 23444033 Free PMC article.
-
Setting priorities in health care organizations: criteria, processes, and parameters of success.BMC Health Serv Res. 2004 Sep 8;4(1):25. doi: 10.1186/1472-6963-4-25. BMC Health Serv Res. 2004. PMID: 15355544 Free PMC article.
-
Evidence based medicine guidelines: a solution to rationing or politics disguised as science?J Med Ethics. 2004 Apr;30(2):171-5. doi: 10.1136/jme.2003.003145. J Med Ethics. 2004. PMID: 15082812 Free PMC article. Review.
-
Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers.Patient. 2016 Jun;9(3):201-22. doi: 10.1007/s40271-015-0139-7. Patient. 2016. PMID: 26370257 Review.
References
-
- Calman K, Hine D. A policy framework for commissioning cancer services. London: Department of Health; 1995. p. 18.
-
- Medicines and the NHS: a guide for directors. Drug Therap Bull. 1997;4:1.
-
- Chustecka Z. UK demands taxol for ovarian cancer. Scrip 1998;2338/39:28.
-
- Halle M. Cancer treatments rationed by authority. BMJ. 1996;313:774. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
